514 related articles for article (PubMed ID: 16335333)
1. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
Morin CM; Koetter U; Bastien C; Ware JC; Wooten V
Sleep; 2005 Nov; 28(11):1465-71. PubMed ID: 16335333
[TBL] [Abstract][Full Text] [Related]
2. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.
Koetter U; Schrader E; Käufeler R; Brattström A
Phytother Res; 2007 Sep; 21(9):847-51. PubMed ID: 17486686
[TBL] [Abstract][Full Text] [Related]
4. Treating primary insomnia - the efficacy of valerian and hops.
Salter S; Brownie S
Aust Fam Physician; 2010 Jun; 39(6):433-7. PubMed ID: 20628685
[TBL] [Abstract][Full Text] [Related]
5. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study.
Chandra Shekhar H; Joshua L; Thomas JV
Adv Ther; 2024 Jan; 41(1):246-261. PubMed ID: 37899385
[TBL] [Abstract][Full Text] [Related]
6. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
7. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial.
Taavoni S; Ekbatani N; Kashaniyan M; Haghani H
Menopause; 2011 Sep; 18(9):951-5. PubMed ID: 21775910
[TBL] [Abstract][Full Text] [Related]
8. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia.
Jacobs BP; Bent S; Tice JA; Blackwell T; Cummings SR
Medicine (Baltimore); 2005 Jul; 84(4):197-207. PubMed ID: 16010204
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.
Taibi DM; Vitiello MV; Barsness S; Elmer GW; Anderson GD; Landis CA
Sleep Med; 2009 Mar; 10(3):319-28. PubMed ID: 18482867
[TBL] [Abstract][Full Text] [Related]
10. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms.
Dimpfel W; Suter A
Eur J Med Res; 2008 May; 13(5):200-4. PubMed ID: 18559301
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
Maroo N; Hazra A; Das T
Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of SM-1 in a transient insomnia model.
Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
[TBL] [Abstract][Full Text] [Related]
14. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
[TBL] [Abstract][Full Text] [Related]
15. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
16. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
Ivgy-May N; Ruwe F; Krystal A; Roth T
Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial.
Glass JR; Sproule BA; Herrmann N; Busto UE
J Clin Psychopharmacol; 2008 Apr; 28(2):182-8. PubMed ID: 18344728
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study.
Li Y; Zhang R; Zhou Y; Bao C; Lin Z; Chen C; He J; Jin Z; Song L; Zhang M; Guo S; Jiang Y; Zhao Z
Sleep; 2024 Feb; 47(2):. PubMed ID: 37864827
[TBL] [Abstract][Full Text] [Related]
19. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
20. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
Scharf M; Erman M; Rosenberg R; Seiden D; McCall WV; Amato D; Wessel TC
Sleep; 2005 Jun; 28(6):720-7. PubMed ID: 16477959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
